Atlas Trials

A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate

Clinical trial NCT01685268 · COMPLETED

Trial details

NCT number
NCT01685268
Sponsor
Astex Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2012-09-01
Primary completion
2014-07-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.